IL6 and COVID-19: According to recent studies, the secretion of cytokines, such as interleukin (IL)-1β, IL6, and IL-10, and mediators such as TNF-α have been significantly stimulated in patients with COVID-19 and are associated with rapid disease progression in high-risk patients [14,15,16,17,18,19].